ValuationViz

CORT fund manager activity

Corcept Therapeutics Incorporated · Nasdaq. Reported by 7 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementTrimmed17,352$603,8500.00%Feb 17, 2026
Polen Capital ManagementSold out——0.00%Feb 12, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementAdded17,362$1,442,9560.01%Nov 14, 2025
Polen Capital ManagementAdded28,363$2,357,2490.01%Nov 12, 2025

Newer quarters · Older quarters